Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Watson-Marlow Fluid Technology Group’s puresu single-use tube assemblies offer reliable, sterile, customisable solutions for bioprocessing

    Oct 31, 2019, 06:24 AM by Michael Croft
    FALMOUTH, UK - Oct 31, 2019 - Watson-Marlow Fluid Technology Group (WMFTG) announces the expansion of its puresu® single-use range, providing a combination of components that are safe and easy-to-install
    Full story
  • Creative BioMart Enhanced Its Protein Kinase Assay Service for Protein Research

    Oct 31, 2019, 01:51 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Oct 31, 2019 - Creative BioMart, a global specialized CRO providing high quality protein analytical services to support research, manufacturing and clinical development of native and recombinant proteins, is glad to enhance its protein kinase assay service recently to help customers accelerate their discovery and to help explore new frontiers in biological science
    Full story
  • Moving the Conversation from Cost to Value: VeraSci Offers New Approach to HEOR and HTA Consulting Led by Dr. Luca Pani

    Oct 30, 2019, 16:50 PM by Michael Croft
    DURHAM, NC, UNITED STATES - Oct 28, 2019 - VeraSci, a leading provider of innovative scientific and technology services, announces the addition of a new service offering, Value Consulting, a HEOR and HTA consulting service line, addressing the emerging need to demonstrate the pharmacoeconomic value of novel therapies earlier in the development process
    Full story
  • Winners of the 2019 President’s Startup Challenge Announced, as The Pistoia Alliance Looks to the Future

    Oct 30, 2019, 12:56 PM by Michael Croft
    BOSTON, MA, UNITED STATES - Oct 30, 2019 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, has announced the winners of the 2019 President’s Startup Challenge at its annual member conference in Boston
    Full story
  • Iceni Diagnostics appoints Chris Liggett to accelerate route-to-market strategy

    Oct 30, 2019, 11:34 AM by Michael Croft
    NORWICH, UNITED KINGDOM - Oct 31, 2019 - As Iceni Diagnostics, developer of glycoscience-based diagnostics, therapies and vaccines, moves closer to market it has appointed Chris Liggett, business strategist and new product development specialist, to support its commercial operations
    Full story
  • Optibrium Announce the Release of StarDrop™ 6.6

    Oct 30, 2019, 05:21 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Oct 30, 2019 - Optibrium™, a developer of software for drug discovery, today announced the introduction of StarDrop™ 6
    Full story
  • Compound Screening Platform Is Launched by BOC Sciences for Drug Discovery Research

    Oct 29, 2019, 21:38 PM by Michael Croft
    SHIRLEY, NY, NY, UNITED STATES - Oct 30, 2019 - With unceasing steps in the field of drug discovery, BOC Sciences, primarily known as an industry-leading chemical vendor, recently launches an efficient, economical and systematic one-stop compound screening platform, in a hope to fulfill the clients’ demand in drug R&D
    Full story
  • Seqster Licenses SRP to La Jolla Institute of Immunology for Asthma Study

    Oct 29, 2019, 18:05 PM by Michael Croft
    Bio-IT World | Seqster has signed a 3-year licensing deal and partnership with La Jolla Institute of Immunology (LJI) to support the execution of a $6.9 million Asthma study.
    Full story
  • MGI Launches Benchtop Sequencing Laboratory And Automation Products

    Oct 29, 2019, 16:10 PM by Michael Croft
    Bio-IT World  Last week MGI released its new one-stop sequencing solution, including the portable “express” sequencing system DNBSEQ E series, the modular “digital biolab” DNBelab D series for use with the sequencing system, and the new DNBelab C series, a handheld single-cell laboratory.
    Full story
  • Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer

    Oct 29, 2019, 12:25 PM by Michael Croft
    HAIFA, ISRAEL - Oct 29, 2019 - MeMed Ltd., a leader in host response-based diagnostic solutions, today announced the addition of Dr
    Full story
  • Alfa Chemistry Launched Microalgae Powder Services

    Oct 29, 2019, 04:58 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Oct 29, 2019 - On October 24, 2019, Alfa Chemistry announced that it has launched microalgae powder production services
    Full story
  • Sterling Pharma Solutions invests $1.5m into US facility expansion

    Oct 28, 2019, 11:43 AM by Michael Croft
    NORTH CAROLINA, N/A - Oct 28, 2019 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing $1
    Full story
  • ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies

    Oct 28, 2019, 10:29 AM by Michael Croft
    SCHILTHIGHEIM, FRANCE - Oct 28, 2019 - For researchers looking to accelerate the development of new immunotechnologies, ProteoGenix has created 2 new naïve rabbit and human antibody phage display libraries
    Full story
  • Half Of Lab Experiments Fail, Costing $28B Annually. How We Can Prevent ‘Unknown Unknowns’

    Oct 28, 2019, 08:50 AM by Michael Croft

    Bio-IT World Contributed Commentary | PLOS Biology published data on the $28 billion lost in preclinical research back in June 2015. It raised a vital question:  What is the life science community actually doing now to prevent this colossal amount of wasted time, money, effort, and inventory?

    Full story
  • A prediction of gene sequencing application areas and scale by CD Genomics

    Oct 28, 2019, 03:47 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Oct 28, 2019 - The upstream of the gene sequencing industry is the supply of sequencing instruments, sequencing reagents and consumables
    Full story
  • BOC Sciences Upgrades Bioconjugation Service to Help Advance Targeted Drug Delivery Research

    Oct 27, 2019, 21:58 PM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Oct 22, 2019 - Targeted drug delivery is by no means easy task, but luckily bioconjugation can be of great assistance
    Full story
  • Creative Proteomics Provides Glycosylation Service for Lab Research

    Oct 25, 2019, 02:34 AM by Michael Croft
    SHIRLEY, NY - Oct 25, 2019 - Since its establishment in 2004, Creative Proteomics has gradually been a leading supplier providing proteomics, glycomics, metabolomics and bioinformatics analysis services
    Full story
  • Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients

    Oct 24, 2019, 14:11 PM by Michael Croft
    HOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences’ Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infection
    Full story
  • The Greatest Medical Advancements Of The Future Will Originate In Data-Driven Enterprises

    Oct 24, 2019, 11:30 AM by Michael Croft

    Bio-IT World Contributed Commentary | Combining the core competencies of life sciences and medicine with data-driven solutions will enable researchers and providers to revolutionize healthcare.

    Full story
  • KCR Announces new Chief Technology Officer

    Oct 24, 2019, 09:15 AM by Michael Croft
    BOSTON, MA, US - Oct 24, 2019 - KCR, an international clinical development solutions provider, has named Douglas Bain the organization’s Chief Technology Officer
    Full story
  • «
  • 241
  • 242
  • 243
  • 244 (current)
  • 245
  • 246
  • 247
  • 248
  • 249
  • 250
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy